You just read:

Novel Drug Treatment Shows Improved Cognition in a Phase 3 Clinical Trial in Persons with Mild-to-Moderate Alzheimer's Disease in China

News provided by

Green Valley Pharmaceutical Co., Ltd.

Oct 25, 2018, 03:15 ET